NCT05414708 Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms
| NCT ID | NCT05414708 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Walter Reed National Military Medical Center |
| Condition | PTSD |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2022-02-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2022-02-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Art therapy is used across the Military Health System for treatment of posttraumatic symptoms, but there is limited research on how art therapy is able to restore emotional expression and regulation in service members. This research hopes to learn about the effects of art therapy on emotional expression and regulation in service members as well as the neurological systems at work. If a participant chooses to be in this study, he or she will attend eleven sessions over a period of six to eight months. The first session will be an interview and self-assessment questionnaires to collect information on a variety of symptoms, experiences, and personality traits, and an MRI scan. During the MRI scan, participants will be asked to perform a task where they will be shown a series of neutral and negative images. The following eight sessions will be one-hour art therapy sessions with a certified art therapist. The tenth session will consist of the same self-assessment questionnaires and another MRI scan. The final session will consist of some of the same questionnaires from the tenth visit, as well as a qualitative interview done virtually three months after the tenth visit.
Eligibility Criteria
Inclusion Criteria: * DEERS Eligible * Active Duty or Veteran separated within the past 10 years * Significant posttraumatic stress symptoms (score of \>/=31 on the PCL-5) Exclusion Criteria: * History of moderate, severe, or penetrating brain injury * History of psychotic disorder, bipolar disorder, or active suicidal or homicidal ideation * History of multiple sclerosis, Huntington's disease, or Alzheimer's disease * History of stroke or myocardial infarction * History of brain tumor * History of seizures * Contradictions for MRI (for example, participants will be excluded for pregnancy, metal implants or suspected shrapnel, aneurysm/intracranial clips, cardiac pacemakers or implanted programmable devices or pumps) * Unable to provide informed consent * History of previous exposure to art therapy * Active substance use disorder
Contact & Investigator
Chandler Rhodes, PhD
PRINCIPAL INVESTIGATOR
WRNMMC
Frequently Asked Questions
Who can join the NCT05414708 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 64 Years, studying PTSD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05414708 currently recruiting?
Yes, NCT05414708 is actively recruiting participants. Contact the research team at chandler.s.rhodes.civ@health.mil for enrollment information.
Where is the NCT05414708 trial being conducted?
This trial is being conducted at Bethesda, United States, Fort Belvoir, United States.
Who is sponsoring the NCT05414708 clinical trial?
NCT05414708 is sponsored by Walter Reed National Military Medical Center. The principal investigator is Chandler Rhodes, PhD at WRNMMC. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.